ASX Announcement 18 April 2024 Results of Extraordinary General Meeting Elixinol Wellness Limited (Elixinol Wellness or the Company) (ASX:EXL) wishes to announce the results of the Company’s Extraordinary General Meeting (EGM) held at 11.00am today. In accordance with ASX Listing Rule 3.13.2, the Company confirms that the resolution in the Notice of Extraordinary General Meeting was passed. The resolution was determined by a poll at the EGM. In accordance with ASX Listing Rule 3.13.2 and section 251AA(2), Corporations Act 2001 (Cth), the Company provides the results of the EGM voting in the attachment to this announcement. This document was authorised to be given to the ASX by the Board of Directors of the Company. Investor relations please contact: David Fenlon, Non-Executive Chair dave.fenlon@elixinolwellness.com Pauline Gately, Non-Executive Director pauline.gately@elixinolwellness.com About Elixinol Wellness Elixinol Wellness Limited (ASX: EXL) is a pioneer in the global hemp industry, innovating, marketing and selling hemp and other plant-derived food, skincare and nutraceutical products: • In Australia, EXL operates a vertically integrated business which produces, manufactures, exports and distributes a range of sustainable and plant-based nutrition brands including Hemp Foods Australia, Mt Elephant, Field Day, Ananda Food and The Australian Superfood Company. EXL sells to grocery, wholesale, e-commerce and white label customers. ● In the Americas, innovating, marketing and selling high quality Elixinol branded hemp and other plant derived nutraceutical and skincare products based in Colorado, USA. ● In the United Kingdom, Japan, Brazil, Mexico and South Africa, branded hemp and other plant-derived products are available to consumers via exclusive distribution and/or trademark and know-how licensing agreements. See more at www.elixinolwellness.com Disclosure of Proxy Votes Automic GPO Box 5193, Sydney, NSW 2001 P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world) F +61 (0)2 8583 3040 E hello@automic.com.au ABN 27 152 260 814 Elixinol Wellness Limited Extraordinary General Meeting Thursday, 18 April 2024 In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting. Poll Results (if applicable) Proxy Votes Resolution 1 Approval to issue securities to Canaccord in connection with the Offer Decided by Show of Hands (S) or Poll (P) P Total Number of Proxy Votes exercisable by proxies validly appointed 203,583,237 FOR AGAINST 81,176,651 19,063,562 39.87% 9.36% ABSTAIN 145,623 PROXY'S DISCRETION FOR AGAINST 103,343,024 207,558,819 19,063,562 50.76% 91.59% 8.41% Results ABSTAIN 145,623 OUTCOME Passed